IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice - Wikidata - wikimedia - TriplyDB

IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice

IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice

http://www.wikidata.org/entity/Q37042990

about

Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in Smad3(-/-) mice with dysregulated TGFβ Understanding the role of the kynurenine pathway in human breast cancer immunobiology The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia Recent advancement in understanding colitis-associated tumorigenesis.Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2 IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.The gut microbiota in mouse models of inflammatory bowel disease.NPC1L1 knockout protects against colitis-associated tumorigenesis in mice.Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.Severity of DSS-induced colitis is reduced in Ido1-deficient mice with down-regulation of TLR-MyD88-NF-kB transcriptional networks Dysregulated expression of IDO may cause unexplained recurrent spontaneous abortion through suppression of trophoblast cell proliferation and migration.An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer Expression Pattern and Clinicopathological Relevance of the Indoleamine 2,3-Dioxygenase 1/Tryptophan 2,3-Dioxygenase Protein in Colorectal Cancer.Metabolic control of tumour progression and antitumour immunity Profiling of mRNA and long non-coding RNA of urothelial cancer in recipients after renal transplantation.Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer.Parallel Expression of Enzyme Inhibitors of CD8T Cell Activity in Tumor Microenvironments and Secretory Endometrium.Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.Role of Dietary Metabolites in Regulating the Host Immune Response in Gastrointestinal Disease.Indoleamine 2,3-dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and is Associated with Type II Hypersensitivity/Autoimmunity.Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.CD44 and TLR4 mediate hyaluronic acid regulation of Lgr5+ stem cell proliferation, crypt fission, and intestinal growth in postnatal and adult mice.Kynurenine pathway metabolites: relevant to vitamin B-6 deficiency and beyond.Quinolinic acid induces neuritogenesis in SH-SY5Y neuroblastoma cells independently of NMDA receptor activation.Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis.Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy.Obesity and Cancer: Existing and New Hypotheses for a Causal Connection.Trypanosoma cruzi Exploits Wnt Signaling Pathway to Promote Its Intracellular Replication in Macrophages.Indoleamine 2,3-dioxygenase-dependent expansion of T-regulatory cells maintains mucosal healing in ulcerative colitis

P2860

Q21559539-89C9DDCC-C909-4641-AD25-32F9278324F1 Q26773472-2684C9A0-FAFB-417A-A839-76375D9B7CEC Q26785900-674C29B2-594F-4EAC-907C-F3B11640A8C6 Q33880455-2F1771DD-491C-413C-8663-228DC66D25AA Q33915720-94C6A757-FB55-4448-832B-4223239A53FB Q34390271-85696719-644A-4B70-B69D-2EB3517E336E Q34669312-7D421E86-DFB1-425F-AF78-61F3D68453A2 Q34776749-6E6C0D12-808C-4BBD-9984-8FBB1E8CE01E Q35117031-1E593A1A-FC65-437B-AB68-987B49F82661 Q35228987-3B123F07-E633-49F3-9D86-3CC71436A8C6 Q36070870-360878C0-42C3-45FE-A41A-F5B78CEA3F9A Q36323786-0EFAC414-E211-4401-B824-AF341C50EABE Q36507598-FFECC77F-E795-42F3-BBD0-927C28743DE8 Q36544900-93AAA142-AAB6-4F3F-8FEA-F6593FFF4938 Q37192986-98032C42-E084-4920-BE48-CF36AEDA3FDF Q38168678-17985BFE-CDF3-448A-9A58-9D87DD651F18 Q38441306-BBE40BAB-C0F3-4366-9A7A-106915B461CB Q38571347-9248E825-B5F6-4138-AEFD-56A2C376264E Q38579710-99C8E543-AE03-4E82-A31D-DCCCD41B28C1 Q38794338-6835D74A-E510-49BA-9C1D-6F7143DFBC54 Q39132612-241F6EDA-6F07-4669-870D-1F8D2F2F008E Q40045246-0C1369F0-A1A7-4860-BECD-AECEAD3E97C4 Q40210981-E7A6C999-ACDA-4591-BE44-A48A87EC74B2 Q42089828-092C6E20-5CD1-4C88-ABAC-5623CCF2D3C8 Q42181705-870B5E88-6126-4AEB-9D01-DFFEE7F6711C Q42335914-DB4297EE-25A7-41A1-8150-B37E605D729B Q46446145-74022FEA-AA00-4910-A1DE-CC11C924BD95 Q47204660-4A5E473B-A87E-44EA-91D8-FB8A9BB1A81E Q50223024-7F61160E-AEBD-47C0-86D2-21CA3B07E553 Q52569152-976FF36E-B26E-4C13-9BED-8B05D5F4F795 Q52662023-E92819EA-8199-43EA-AAC8-84C2E1F60310 Q55314147-F91A6F54-D435-4BFC-8DF9-207444E46B59 Q58707093-2909C588-E560-49EE-BE7C-02C2C38E80CA

P2860

IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice

http://www.wikidata.org/entity/Q37042990

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

IDO1 metabolites activate β-ca ...... nd colon tumorigenesis in mice

@en

IDO1 metabolites activate β-ca ...... d colon tumorigenesis in mice.

@nl

type

label

IDO1 metabolites activate β-ca ...... nd colon tumorigenesis in mice

@en

IDO1 metabolites activate β-ca ...... d colon tumorigenesis in mice.

@nl

prefLabel

IDO1 metabolites activate β-ca ...... nd colon tumorigenesis in mice

@en

IDO1 metabolites activate β-ca ...... d colon tumorigenesis in mice.

@nl

P1433

Q37042990-8AA595F9-44AE-42A4-9DF9-D43F9B3E5596

P1476

Q37042990-5F515753-4341-430E-AB9C-5DB682BE5B4A

P2093

Q37042990-01A2CBF2-C252-44CC-B95F-89D3BD3412E9

Q37042990-0F8C73BB-EED2-4B99-AF49-A3E3825642D8

Q37042990-1FDE082B-FBB3-49F9-AC8E-5E2CAC655268

Q37042990-42A5D7CA-BA16-414B-A86D-039DB1C929D4

Q37042990-65FA6FED-F7ED-4583-8FFA-E3311B95730E

Q37042990-6DE80A51-FF70-4984-9B82-DB34CBD97D78

Q37042990-8EE7787B-2F7B-44B6-BD0A-333227CA3F7E

Q37042990-BB647A1F-6C14-471E-9F7D-971DF81C980C

P2860

Q37042990-026300E4-2512-4BBC-9A73-2F3530F6747C

Q37042990-065066C5-4A3C-4737-A533-F28812290B9A

Q37042990-0B09D87E-0A1D-4CC5-8248-0BA3412A1A79

Q37042990-0B544E36-A517-4611-948F-A1324DF2188D

Q37042990-1D2A0268-C2A5-4A63-8562-69B2902F0C73

Q37042990-1F0EA797-3BDB-4A0A-86B3-F1D3F36C1C6A

Q37042990-20D4370E-935F-4B70-8B33-F22C59876A43

Q37042990-21FD9B1D-BFCF-43D2-A10B-B349933F281C

Q37042990-227CC79C-ED20-4BB5-95A6-3ED77BEB3906

Q37042990-29594004-0FB3-48BC-AFCC-334512410C18

P304

Q37042990-280EF95C-247F-4D1A-89A3-9204FBE90A4A

P31

Q37042990-62380780-034C-4917-8F3C-3F334E2BCF1D

P356

Q37042990-BD9CC456-3D44-4E59-BC02-44D71FAC07ED

P407

Q37042990-3D204A88-A4AE-4562-8772-006771AD63A2

P433

Q37042990-E03F9BE5-0616-4621-81F0-AF13672BDC3A

P478

Q37042990-8E8E0A39-516B-490B-A82F-8726691C2554

P50

Q37042990-96152B21-045D-416A-9DD4-2BFFDF3B2962

P577

Q37042990-14763C64-666A-45FC-81F1-4FE7EB90DFC5

P698

Q37042990-0A95E8D6-1D21-47D9-922C-325A47BC86EB

P932

Q37042990-BD65AE5B-9D0C-4519-9150-97012B7862F3

P356

J.GASTRO.2013.05.002

P1433

Gastroenterology

P1476

IDO1 metabolites activate β-ca ...... nd colon tumorigenesis in mice

@en

P2093

Ameet I Thaker

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Marinshaw

http://www.w3.org/2001/XMLSchema#string

Kumar S Bishnupuri

http://www.w3.org/2001/XMLSchema#string

Lynne Foster

http://www.w3.org/2001/XMLSchema#string

M Suprada Rao

http://www.w3.org/2001/XMLSchema#string

Matthew A Ciorba

http://www.w3.org/2001/XMLSchema#string

Thomas A Kerr

http://www.w3.org/2001/XMLSchema#string

William F Stenson

http://www.w3.org/2001/XMLSchema#string

P2860

Wnt/beta-catenin signaling and small molecule inhibitors

Indoleamine 2,3 dioxygenase in intestinal disease

PTEN-deficient intestinal stem cells initiate intestinal polyposis.

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.

Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis

Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis.

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

P304

416-25.e1-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2013.05.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

145

http://www.w3.org/2001/XMLSchema#string

P50

Rodney D. Newberry

P577

2013-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23669411

http://www.w3.org/2001/XMLSchema#string

P932

3722304

http://www.w3.org/2001/XMLSchema#string